A Guide to Benzodiazepine Selection. Part II: Clinical Aspects
The DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
To suit the specific needs of various clinical situations, selection of an appropriate benzodiazepine derivative should be based on consideration of their different pharmacokinetic and pharmacodynamic properties. Benzodiazepine derivatives that are rapidly eliminated produce the most pronounced rebound and withdrawal syndromes. Benzodiazepines that are slowly absorbed and slowly eliminated are most appropriate for the anxious patient, since these derivatives produce a gradual and sustained anxiolytic effect. Rapidly absorbed and slowly eliminated benzodiazepines are usually more appropriate for patients with sleep disturbances, since the rapid absorption induces sleep and the slower elimination rate may induce less tolerance to the sedative effect. Rational selection of a benzodiazepine for the elderly and for the suspected drug abuser is more problematic. The relevant pharmacokinetic and clinical considerations for these users are discussed. Certain derivatives may possess pharmacodynamic properties not shared by the entire benzodiazepine class; empirical studies have suggested the existence of antipanic properties for alprazolam and clonazepam, antidepressant properties for alprazolam, and anti-manic properties for clonazepam and possibly lorazepam.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, clonazepam’s favorable pharmacokinetic profile (longer alpha and beta half-lives) lends itself to less plasma fluctuations and inter-dose withdrawal anxiety despite its high potency (Teboul & Chouinard, 1991).”
From Pharmacological principles for safe benzodiazepine and Z-drug dose reduction (2026) · cites this paper as Teboul & Chouinard, 1991
In the citing paper
“Rebound anxiety was also observed [1, 38, 50].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [38]
In the citing paper
“More new withdrawal symptoms were found upon discontinuation of lorazepam (high potency and short-acting) than with diazepam [38].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [38]
Citations
Cites
Risk Factors for Falls among Elderly Persons Living in the Community
Tinetti, M. E., Speechley, M., & Ginter, S. F. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192604 · Cited by 6,509
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Benzodiazepines of Long and Short Elimination Half-life and the Risk of Hip Fracture
Ray, W. A. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430230088031 · Cited by 548
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
PSYCHIATRIC REACTION PATTERNS TO IMIPRAMINE
KLEIN, D. F., & FINK, M. (1962) · American Journal of Psychiatry · doi:10.1176/ajp.119.5.432 · Cited by 416
Anxiety: New Research and Changing Concepts
Goldberg, A. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320300091046 · Cited by 389
Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610023151403 · Cited by 369
Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo
Zitrin, C. M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790020019002 · Cited by 342
Research works printed but not linked: 46
- Vogel G.W., 1976, J Clin Pharmacol, 47, 81
- Dement W.C., 1978, Behav Med, 5, 25
- Kales A., 1978, Behav Med, 5, 25
- Chouinard G., 1986, J Clin Psychiatry Monograph Series, 4, 12
- Noyes R., 1988, J Clin Psychiatry, 49, 382
- Chouinard G., 1988, Can Med Assoc J, 139, 119
- Fontaine R., 1987, Efficacy and rebound anxiety of zopiclone and triazolam.
- Herman J.B., 1987, J Clin Psychiatry, 48, 22
- Petersson H., 1984, Dependence on tranquilizers.
- Rickels K., 1986, Psychopharmacol Bull, 22, 407
- 10.1001/jama.1977.03270280038018 · doi:10.1001/jama.1977.03270280038018 · Paper page
- Busto U., 1986, Acta Pharmacol Toxicol (Copenh), 203
- Ongini E., 1985, Clin Neuropharmacol, 8, 517
- Healey M., 1983, J Clin Psychiatry, 44, 436
- Mac D.S., 1985, J Clin Psychiatry, 46, 137
- Spinweber C.L., 1985, Sleep Res, 14, 60
- Scharf M.B., 1984, J Clin Psychiatry, 45, 51
- Scharf M.B., 1983, J Clin Psychiatry, 44, 362
- Scharf M.B., 1985, J Clin Psychiatry, 46, 518
- 10.1001/jama.1987.03400070083040 · doi:10.1001/jama.1987.03400070083040
- Annitto W.J., 1989, Am J Psychiatry, 145, 683
- Ciraulo D.A., 1989, Am J Psychiatry, 145, 684
- Kryspin-Exner K., 1975, Int J Clin Pharmacol, 12, 13
- Ciraulo D.A., 1988, J Clin Psychiatry, 49, 333
- Sheehan D.V., 1982, Drug Ther Hosp, 7, 74
- Beaudry P., 1986, J Clin Psychiatry, 47, 83
- Tesar G.E., 1987, J Clin Psychiatry, 48, 16S
- Annable L., 1989, VIII World Congress of Psychiatry, Book of Abstracts, 422, 116
- Cassano G.B., 1973, The benzodiazepines.
- Fabre L.F., 1976, Curr Ther Res, 19, 661
- Fabre L.F., 1980, Curr Ther Res, 27, 474
- Lenox R.H., 1984, Psychopharmacol Bull, 20, 79
- Overall J.E., 1987, J Clin Psychiatry, 48, 51
- Overall J.E., 1987, J Clin Psychiatry, 48, 15
- Sethy V.H., 1982, Res Commun Chem Pathol Pharmacol, 36, 329
- Dunner D., 1987, J Clin Psychiatry, 7, 170
- Falk W.E., 1986, Biological Therapies in Psychiatry, 9, 6
- Rapaport M., 1985, Am J Psychiatry, 141, 146
- Mayerhoff D., 1986, NY State J Med, 86, 320
- Goodman W.K., 1987, J Clin Psychiatry, 48, 117
- Dubin W.R., 1988, J Clin Psychiatry, 49, 5
- Chouinard G., 1983, Biol Psychiatry, 4, 451
- Chouinard G., 1989, Clonazepam in acute mania and manic spectrum diseases, 315
- Harms L., 1985, Pharmabulletin (Health Department of Victoria, Australia), 104, 117
- Freinhar J.P., 1985, J Clin Psychiatry, 46, 29
- Modell J.G., 1986, J Clin Psychopharmacol, 6, 385
Cited by
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 534
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationOffidani, E., Guidi, J., Tomba, E., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000353198 · Cited by 166
Egan, M., Moride, Y., Wolfson, C., & Monette, J. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04758.x · Cited by 109
Similitude in modern pharmacology
Teixeira, M. Z. (1999) · British Homeopathic journal · doi:10.1054/homp.1999.0301 · Cited by 70
Metadata
- Authors
- Teboul, E., & Chouinard, G.
- Affiliations
- McGill University (CA)
- Institut universitaire en santé mentale de Montréal (CA)
- ORCID
- Teboul, Eric
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 1991-02
- Volume
- 36
- Issue
- 1
- Pages
- 62-73
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W142572826
- Cited by
- 25
- References
- 148
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 1 · 2020: 1 · 2015: 1 · 2013: 1
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- benzodiazepines, pharmacokinetics, pharmacodynamics, anxiolytic effects, sleep disorders, elderly patients, drug abusers, alprazolam, clonazepam, lorazepam, antidepressant effects
- MeSH terms
- Aged, Anxiety Disorders, Benzodiazepines, Depressive Disorder, Dose-Response Relationship, Drug, Humans, Panic, Psychomotor Agitation, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Guide to Benzodiazepine Selection. Part II: Clinical Aspects. https://app.cochat.ai/papers/10.1177/070674379103600117
- The paper
- Teboul, E., & Chouinard, G. (1991). A Guide to Benzodiazepine Selection. Part II: Clinical Aspects. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379103600117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.